Syracuse, NY · Founded 2015 · Privately Held (backing)
Developer of a small molecule-based osteoinductive technology designed to suspend cancer, inhibit pain and regenerate bone. ZetaGen Therapeutics is based in Syracuse, NY and was founded in 2015. It was valued at $180 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $52.5 million across 4 recorded rounds; the latest was a $12.9 million early-stage round in Jan 2025.
5 investors are on record for ZetaGen Therapeutics, including National Institutes of Health, New York Ventures, AJU IB Investment and JStar Capital. The early-stage round in Jan 2025 drew 35 investors.
Free account
More of ZetaGen Therapeutics with a free account
·Watch ZetaGen Therapeutics: the Monday email on marks, rounds and moves
These 5 firms already write checks for companies like ZetaGen Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.